Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

Marie Skłodowska-Curie Action · Running

SUPRA-MED SUpersaturation and Phase-separation Research on Drug Absorption: Mechanistic Evaluation in Pharmaceutical Development

Coordinator
University College Cork - National University of Ireland, Cork, Ireland
Runs
1 May 2026 to 30 April 2028
Status
Running
EU funding
€269k
Total cost
—
Partners
2 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101271409

What the project is doing

In the project's own words, from its summary on CORDIS.

The central scientific objective of this project is to establish a mechanistic framework for predicting oral drug absorption from supersaturating formulations by developing a decision tree for rational in vitro method selection and validating robust in vitro–in vivo relationships. This approach will minimise reliance on animal studies, reduce the number of costly and time-consuming experimental iterations required during formulation optimisation, and ultimately accelerate the pathway from discovery to patient access.

Supersaturating formulations will be extensively characterised using a suite of advanced physicochemical and in vitro tools, ranging from dissolution–permeation assays with artificial barriers to physiologically relevant intestinal organoid cultures. Techniques including Dynamic Light Scattering, Polarised Light Microscopy, Fluorescence and Raman spectroscopy, and Broadband Acoustic Resonance Dissolution Spectroscopy will enable detailed characterisation of drug-rich colloidal species and their interactions with the intestinal epithelium.

The outcome will be a decision tree guiding the rational selection of in vitro methods for evaluating supersaturating formulations, supported by mechanistic insights into LLPS and nano-crystal-mediated absorption. The developed methodologies & decision tree will be validated to TRL Level 6 during the industrial secondment. The fellowship will be carried out in an intersectoral environment, bringing together leading academic and industrial partners with extensive experience in training, innovation, and translational science.

The fellow will gain expertise in advanced in vitro methodologies, while also acquiring transferable skills in scientific writing, communication, and leadership. Secondments in the pharmaceutical industry will provide first-hand experience of product development pathways, IP management, and regulatory strategy, positioning the fellow for a future career at the interface of academia and industry.

Topics

Who is involved

OrganisationCityCountryRole
University College Cork - National University of Ireland, CorkCorkIrelandCoordinator
Novartis International AGBaselSwitzerlandAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI